BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Nosology
,
Lovastatin
,
rs4950928
,
BRCA1
,
Metabolism of xenobiotics
,
Obesity
,
Heart
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
proteasome inhibitor
Summary
General Info
Curated Studies
Most Correlated Studies
Heat shock response induced by both elevated temperature and a proteasome inhibitor
Multiple myeloma LP-1 cells resistant to proteasome inhibitor carfilzomib
Gene expression profile in HEK293 cells treated with proteasome inhibitor epoxomicin
Ewing's sarcoma cells treated with 20S proteasome inhibitors and novel benzyl-4-piperidone analogs
Proteasome inhibition affects on estrogen-dependent gene transcription
Explore Curated Studies Results
Literature
Most Relevant Literature
Proteasome inhibitors.
MG132, a proteasome inhibitor, induces apoptosis in tumor cells.
Molecular mechanisms of acquired proteasome inhibitor resistance.
New proteasome inhibitors in myeloma.
Proteasome inhibitors and bone disease.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Study of GSK2110183 in Subjects With Proteasome Inhibitor Refractory Multiple Myeloma
Nelfinavir as Bortezomib-sensitizing Drug in Patients With Proteasome Inhibitor-nonresponsive Myelom…
A Study to Evaluate the Efficacy and Safety of Ixazomib in Combination With Lenalidomide and Dexamet…
A Study of DARZALEX (Daratumumab) In Indian Participants With Relapsed and Refractory Multiple Myelo…
Study Augmenting TAK-659 Action in Relapsed/Refractory AML by Addition Ofthe Proteasome Inhibitor Ix…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ